[ad_1]
Healthcare workers and RSAs interested in administration “will be identified on the basis of specific regional lists.” This was announced by the general director of Aifa, Nicola Magrini
Healthcare workers and RSAs interested in administration “will be identified on the basis of specific regional lists.” This was announced by the general director of Aifa, Nicola Magrini
2 ‘reading
“In this first phase but also for the later phases, during the first 2 or 3 months, the vaccine will be coordinated and administered through the commissioner and the regions.” Healthcare professionals and RSAs interested in administering the vaccine “will be identified on the basis of specific regional lists.” Therefore, during the next months there will be no reserve mechanism but a call mechanism ”. This was done by the general director of the Italian Medicines Agency (Aifa), Nicola Magrini, during the press conference on the administration of the Covid-19 vaccine. “Later, with the participation of family doctors, he concluded, we will see how it is done.”
Health professionals first
Vaccination against Covid-19 in Italy “will begin on Sunday with a limited group of health workers. Then all health workers, about a million, will be vaccinated in January. So the folks at RSA, for a similar volume of population. Subsequently, populations at risk, the elderly or people with specific pathologies “, explained Magrini during the meeting with the press:” The 27th is V-day at the European level: this is also a great step forward, in symbolic terms feeling part of a large community, in the context of a global pandemic ”.
Loading…
Vaccine approved for ages 16 and over
“The vaccine is approved for the entire population over 16 years of age and has no absolute contraindications. No special precautions are required for specific subpopulations or for the elderly or immunosuppressed, including those with bleeding or blood clotting problems. Even for pregnancy and lactation, which were said to be absolute contraindications, they are not, because even in this case the benefits outweigh the risks, ”Magrini explained.
Dosage and pharmacovigilance
“The second dose of the vaccine is administered 3 weeks after the first and the immune response of the first dose is already visible from the sixth or seventh day. In the rare hypothesis that one becomes infected in this short period of time, it is probably in a milder form, “he added.
Regarding the Pfizer-Biontech vaccine, the director of Aifa specified that during 2021 active pharmacovigilance programs will be implemented with reminders of patients and text messages with analysis capabilities at 3, 6 and 9 months to understand the immune response in the population . Italian.
